Launches Indigo ® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer ALAMEDA, Calif.--(BUSINESS WIRE)- ...

Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...

Offering a new option for physicians to address arterial thrombus removal, the Indigo System Lightning 7 combines the new Indigo System CAT™7 Aspiration Catheter with Lightning Intelligent Aspiration ...

Now available in the U.S., RED ™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...

ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ® XL System, the longest, largest ...

BOSTON, Mass. - July 27, 2016 - Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that the Penumbra 3D Trial successfully met the primary trial endpoints, ...

Today during the Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting, SNIS President Donald Frei, MD, announced that the Penumbra 3D Trial successfully met the primary trial endpoints, ...

HOUSTON - Feb. 22, 2017 - Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced the presentation of the results of the ASTER Trial, the first independent, prospective, ...

Wells Fargo said that based on early feedback from physicians, the recent launch of Penumbra's (NYSE:PEN) Lightning Flash mechanical thrombectomy system will boost growth for the company. The device ...

Penumbra Inc. presented new data at the LINC Symposium in Leipzig, Germany, evaluating its Indigo aspiration system for submassive pulmonary embolism (PE). The subgroup analysis evaluated performance ...